1. Home
  2. LBRDA vs RGEN Comparison

LBRDA vs RGEN Comparison

Compare LBRDA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBRDA
  • RGEN
  • Stock Information
  • Founded
  • LBRDA 2014
  • RGEN 1981
  • Country
  • LBRDA United States
  • RGEN United States
  • Employees
  • LBRDA N/A
  • RGEN N/A
  • Industry
  • LBRDA Cable & Other Pay Television Services
  • RGEN Medical/Dental Instruments
  • Sector
  • LBRDA Telecommunications
  • RGEN Health Care
  • Exchange
  • LBRDA Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • LBRDA 13.4B
  • RGEN 8.0B
  • IPO Year
  • LBRDA N/A
  • RGEN N/A
  • Fundamental
  • Price
  • LBRDA $96.39
  • RGEN $123.57
  • Analyst Decision
  • LBRDA Buy
  • RGEN Buy
  • Analyst Count
  • LBRDA 3
  • RGEN 12
  • Target Price
  • LBRDA $94.00
  • RGEN $170.40
  • AVG Volume (30 Days)
  • LBRDA 201.9K
  • RGEN 787.0K
  • Earning Date
  • LBRDA 08-07-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • LBRDA N/A
  • RGEN N/A
  • EPS Growth
  • LBRDA 6.21
  • RGEN N/A
  • EPS
  • LBRDA 6.26
  • RGEN N/A
  • Revenue
  • LBRDA $1,037,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • LBRDA $5.22
  • RGEN $13.93
  • Revenue Next Year
  • LBRDA $2.34
  • RGEN $14.35
  • P/E Ratio
  • LBRDA $15.55
  • RGEN N/A
  • Revenue Growth
  • LBRDA 5.82
  • RGEN 4.88
  • 52 Week Low
  • LBRDA $51.58
  • RGEN $102.97
  • 52 Week High
  • LBRDA $102.38
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • LBRDA 51.55
  • RGEN 48.29
  • Support Level
  • LBRDA $87.48
  • RGEN $115.86
  • Resistance Level
  • LBRDA $95.15
  • RGEN $126.61
  • Average True Range (ATR)
  • LBRDA 1.98
  • RGEN 4.43
  • MACD
  • LBRDA -0.04
  • RGEN -0.07
  • Stochastic Oscillator
  • LBRDA 62.50
  • RGEN 42.95

About LBRDA Liberty Broadband Corporation

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: